F. Zhang

Sample size estimation for a flexible phase II oncology trial design using two dependent endpoints with nested response metrics.

Phase II oncology trials are often designed using a single primary efficacy endpoint, even when multiple clinically relevant response metrics are available. When two endpoints are based on nested response metrics, such as objective response rate and disease control rate or progression-free survival at two ordered time...